Ulcerative Colitis Clinical Trial
Official title:
Ileal Pouch Salvage and Excision Operations: Indications, Complications and Outcomes
Procedure is offered today to most patients with chronic ulcerative colitis (CUC) or familial adenomatous polyposis (FAP) who are candidates for total proctocolectomy. While high rates of successful pouch surgery are reported, there is a significant long-term risk of pouch-related complications including ileo-anal anastomotic separation and stricture, pouch-perineal and pouch-vaginal fistula, pouchitis, pelvic sepsis, small bowel obstruction, and pouch dysfunction. Despite recent advances in treatment of these complications by medical and surgical means, these problems can still lead to pouch failure and pouch excision. The long-term rate of pouch excision is reported in large series to range from 5.3% to 24%. Moreover, the burden of quality of life impairment on patients with these complications is immense. Pouch excision operations are technically difficult with substantial morbidity. This study aimed to investigate the indications for pouch excision, the number of salvage operations prior to these excisions and complications of pouch excision surgeries.
Data Collection Data were collected by retrospective review of a single institution, single
practice, prospectively maintained clinical database consisting of 1263 patients undergoing
RPC with IPAA performed between 1981 and 2015. All cases of pouch excision were identified.
The recorded data comprised of patient demographic details, pathologic diagnoses at the time
of pouch formation and pouch excision, details on the surgical procedures performed including
formation of the pouch, procedures performed attempting to salvage the pouch, excision of the
pouch, and intraoperative and early (within 30 days after pouch excision surgery)
complications.
Pouch Salvage Surgery The type and date of all pouch salvage surgical interventions performed
under general anesthesia prior to pouch excision were documented and categorized. We
documented and classified each trip to the operating room as a salvage encounter. Salvage
procedures were defined as any surgical intervention performed to preserve the pouch and did
not include procedures unrelated to the pouch, such as incisional hernia repairs. Operative
salvage procedures included abscess drainage with incision and drainage of an abscess cavity
and curettage of peri-pouch abscesses or fistula tracts. Fistula repair included any repair
of peri-pouch fistulae including seton placement and advancement flap. Any transanal or
abdominal repair or revision of the pouch including the pouch-anal anastomosis was classified
as a pouch revision. Diversion was defined as the formation of any unplanned diverting loop
ileostomy. Ileostomy reversal was defined as the restoration of continuity following an
unplanned diversion. Loop ileostomies formed or reversed as part of a planned, staged RPC
procedure were excluded. Other procedures included dilatation of the IPAA anastomosis with
examination under anesthesia (EUA), formation of an entero-pouch bypass, and any resections
of peri-pouch cysts or desmoids.
Indications for Pouch Excision Indications for pouch excision were based on documented
preoperative clinical and histopathologic diagnoses. Pouch dysfunction was defined as stool
incontinence with or without obstructed defecation. Pouchitis was separately defined as
clinical symptoms of bleeding, cramping abdominal pain, anal discharge, tenesmus, urgency,
and increased frequency of defecation [10]. Distinguishing between pouchitis and pouch
dysfunction was based on the operating surgeon's preoperative clinical diagnosis rather than
pathology. Septic complications included any pelvic, perineal, or perianal infection as a
result of anastomotic dehiscence, abscess or persistent fistula arising from the pouch or
IPAA. Other indications for pouch excision included cancer diagnosed from endoscopic biopsy
or found at surgery. Pouch necrosis was defined as complete transmural ischemia of the pouch.
Summary Measures and Statistical Analyses. Summary statistics of continuous variables
reported the mean and standard deviation (SD) and the median and interquartile range (IQR) as
appropriate. Pouch survival was defined as the time between pouch formation and pouch
excision surgeries. The rate of salvage encounters was calculated by the sum of all
encounters in the operating room where the primary surgery was to salvage the pouch divided
by the number of patients. Differences in pouch survival by indication for pouch excision
were compared using log-rank test. Statistical significance was defined as P<0.05.
Excluded and Missing Data Missing data were not included in the analyses. One patient with
FAP had her pouch formed in our center, sought care at an outside institution for her pouch
excision and the indication for pouch excision was unknown. However, data collected at the
time of pouch formation and salvage procedures performed on this patient prior to excision
were available and included in the analyses. Another patient developed pouch necrosis two
weeks after pouch formation surgery, the pouch was never functional, and this patient was not
included in our analyses of pouch survival or salvage encounter rates.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05702879 -
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
|
||
Not yet recruiting |
NCT05953402 -
A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
|
||
Recruiting |
NCT05316584 -
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
|
N/A | |
Recruiting |
NCT03950232 -
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
|
Phase 3 | |
Completed |
NCT03124121 -
Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels
|
Phase 4 | |
Not yet recruiting |
NCT06100289 -
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
|
Phase 3 | |
Withdrawn |
NCT04209556 -
A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis
|
Phase 2 | |
Terminated |
NCT00061282 -
Clotrimazole Enemas for Pouchitis in Children and Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT04398550 -
SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis
|
N/A | |
Recruiting |
NCT04314375 -
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
|
Phase 4 | |
Active, not recruiting |
NCT04857112 -
Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis
|
Phase 2 | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Active, not recruiting |
NCT04033445 -
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05428345 -
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
|
||
Active, not recruiting |
NCT06221995 -
Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery
|
||
Recruiting |
NCT04767984 -
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
|
Phase 2 | |
Completed |
NCT02508012 -
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
|
N/A | |
Recruiting |
NCT06071312 -
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
|
Phase 1/Phase 2 | |
Completed |
NCT03760003 -
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
|
Phase 2 | |
Not yet recruiting |
NCT05539625 -
Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis
|
Phase 2 |